PMDA — authorised 23 December 2022
- Marketing authorisation holder: Kyowa Kirin Co., Ltd.
- Status: approved
🇯🇵 Mitozytrex in Japan
PMDA authorised Mitozytrex on 23 December 2022
Marketing authorisation
Mitozytrex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Mitozytrex approved in Japan?
Yes. PMDA authorised it on 23 December 2022.
Who is the marketing authorisation holder for Mitozytrex in Japan?
Kyowa Kirin Co., Ltd. holds the Japanese marketing authorisation.